Figure S3 from CRISPR-Cas9 Screening Identifies Resistance Mechanisms to KRAS Inhibition in Pancreatic Cancer

2026 Open access

Read full text
Authors: Szu-Aun Long, Haley Todd, Grace Goodhart, Wen-Hsuan Chang, Amber M. Amparo, Rachel Bridgens, Julien Dilly, Se Jun Park, Robert M. Beal, Sara M. Shehadeh, Megan A. Satyadi, Vidushi K. Trivedi
+13 more Sarah E. Ackermann, Raivath Mukherjee, Craig M. Goodwin, A. Tudor Edwards, Clint A. Stalnecker, Kenneth D. Greis, Andrew J. Aguirre, G. Aaron Hobbs, Kirsten L. Bryant, Syed Kamran Ahmad, Adrienne D. Cox, Channing J. Der, Andrew M. Waters
DOI: 10.1158/0008-5472.31345620
Cited by: 0

Abstract

GSEA analysis of cell lines with and without RMC-7977 + erlotinib synergy.

Fields of Study & Subjects

Pancreatic and Hepatic Oncology Research CRISPR and Genetic Engineering Protein Kinase Regulation and GTPase Signaling

Publication details

Publication date
16 February 2026
Language
EN